The abuse liability of dextromethorphan among adolescents: A review

William V Bobo, Shannon C. Miller, Bryant D. Martin

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Dextromethorphan (DM) is a popular over-the-counter antitussive medication. Although adverse effects from appropriate use are rare, a specific toxidrome with significant psychomimetic effects occurs with ingestions in excess of those recommended. Both DM and its active metabolite, dextrorphan (DOR), share pharmacologic and neuro-behavioral properties similar to opiates and phencyclidine (PCP). As such, cases of recreational DM abuse and, rarely, dependence, have been reported, and some data suggest that such abuse is on the rise. DM may be considered by substance abusers, especially adolescents, to be a dissociative agent devoid of financial concerns, legal limitations, negative stigma, problems with access or adverse health consequences. However, DM's popularity among adolescent substance abusers is generally not matched by adequate health care provider awareness, pharmacological understanding or epidemiological characterization. In this review, we summarize the current understanding of DM's addiction medicine-based neuropharmacology and epidemiology, describe social characteristics more unique to DM as an agent of abuse, review treatment and prevention issues, and identify areas in need of further research.

Original languageEnglish (US)
Pages (from-to)55-75
Number of pages21
JournalJournal of Child and Adolescent Substance Abuse
Volume14
Issue number4
DOIs
StatePublished - 2005
Externally publishedYes

Fingerprint

Dextromethorphan
liability
abuse
adolescent
social characteristics
PCP
epidemiology
medicine
health care
metabolite
health consequences
Opiate Alkaloids
addiction
Dextrorphan
popularity
Neuropharmacology
Antitussive Agents
medication
Phencyclidine
Health Personnel

Keywords

  • Cough medicine
  • Dextromethorphan
  • Dextromethorphan abuse
  • Dextromethorphan dependence
  • Non-prescription medication
  • Substance abuse
  • Substance related disorders

ASJC Scopus subject areas

  • Development
  • Social Psychology
  • Psychology(all)
  • Public Health, Environmental and Occupational Health

Cite this

The abuse liability of dextromethorphan among adolescents : A review. / Bobo, William V; Miller, Shannon C.; Martin, Bryant D.

In: Journal of Child and Adolescent Substance Abuse, Vol. 14, No. 4, 2005, p. 55-75.

Research output: Contribution to journalArticle

@article{0fdfacf5e0b341a7b76d7f90d2ccd937,
title = "The abuse liability of dextromethorphan among adolescents: A review",
abstract = "Dextromethorphan (DM) is a popular over-the-counter antitussive medication. Although adverse effects from appropriate use are rare, a specific toxidrome with significant psychomimetic effects occurs with ingestions in excess of those recommended. Both DM and its active metabolite, dextrorphan (DOR), share pharmacologic and neuro-behavioral properties similar to opiates and phencyclidine (PCP). As such, cases of recreational DM abuse and, rarely, dependence, have been reported, and some data suggest that such abuse is on the rise. DM may be considered by substance abusers, especially adolescents, to be a dissociative agent devoid of financial concerns, legal limitations, negative stigma, problems with access or adverse health consequences. However, DM's popularity among adolescent substance abusers is generally not matched by adequate health care provider awareness, pharmacological understanding or epidemiological characterization. In this review, we summarize the current understanding of DM's addiction medicine-based neuropharmacology and epidemiology, describe social characteristics more unique to DM as an agent of abuse, review treatment and prevention issues, and identify areas in need of further research.",
keywords = "Cough medicine, Dextromethorphan, Dextromethorphan abuse, Dextromethorphan dependence, Non-prescription medication, Substance abuse, Substance related disorders",
author = "Bobo, {William V} and Miller, {Shannon C.} and Martin, {Bryant D.}",
year = "2005",
doi = "10.1300/J029v14n04_04",
language = "English (US)",
volume = "14",
pages = "55--75",
journal = "Journal of Child and Adolescent Substance Abuse",
issn = "1067-828X",
publisher = "Routledge",
number = "4",

}

TY - JOUR

T1 - The abuse liability of dextromethorphan among adolescents

T2 - A review

AU - Bobo, William V

AU - Miller, Shannon C.

AU - Martin, Bryant D.

PY - 2005

Y1 - 2005

N2 - Dextromethorphan (DM) is a popular over-the-counter antitussive medication. Although adverse effects from appropriate use are rare, a specific toxidrome with significant psychomimetic effects occurs with ingestions in excess of those recommended. Both DM and its active metabolite, dextrorphan (DOR), share pharmacologic and neuro-behavioral properties similar to opiates and phencyclidine (PCP). As such, cases of recreational DM abuse and, rarely, dependence, have been reported, and some data suggest that such abuse is on the rise. DM may be considered by substance abusers, especially adolescents, to be a dissociative agent devoid of financial concerns, legal limitations, negative stigma, problems with access or adverse health consequences. However, DM's popularity among adolescent substance abusers is generally not matched by adequate health care provider awareness, pharmacological understanding or epidemiological characterization. In this review, we summarize the current understanding of DM's addiction medicine-based neuropharmacology and epidemiology, describe social characteristics more unique to DM as an agent of abuse, review treatment and prevention issues, and identify areas in need of further research.

AB - Dextromethorphan (DM) is a popular over-the-counter antitussive medication. Although adverse effects from appropriate use are rare, a specific toxidrome with significant psychomimetic effects occurs with ingestions in excess of those recommended. Both DM and its active metabolite, dextrorphan (DOR), share pharmacologic and neuro-behavioral properties similar to opiates and phencyclidine (PCP). As such, cases of recreational DM abuse and, rarely, dependence, have been reported, and some data suggest that such abuse is on the rise. DM may be considered by substance abusers, especially adolescents, to be a dissociative agent devoid of financial concerns, legal limitations, negative stigma, problems with access or adverse health consequences. However, DM's popularity among adolescent substance abusers is generally not matched by adequate health care provider awareness, pharmacological understanding or epidemiological characterization. In this review, we summarize the current understanding of DM's addiction medicine-based neuropharmacology and epidemiology, describe social characteristics more unique to DM as an agent of abuse, review treatment and prevention issues, and identify areas in need of further research.

KW - Cough medicine

KW - Dextromethorphan

KW - Dextromethorphan abuse

KW - Dextromethorphan dependence

KW - Non-prescription medication

KW - Substance abuse

KW - Substance related disorders

UR - http://www.scopus.com/inward/record.url?scp=26944458820&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=26944458820&partnerID=8YFLogxK

U2 - 10.1300/J029v14n04_04

DO - 10.1300/J029v14n04_04

M3 - Article

AN - SCOPUS:26944458820

VL - 14

SP - 55

EP - 75

JO - Journal of Child and Adolescent Substance Abuse

JF - Journal of Child and Adolescent Substance Abuse

SN - 1067-828X

IS - 4

ER -